Plus Therapeutics (PSTV) Gross Margin (2011 - 2019)
Plus Therapeutics (PSTV) reported Gross Margin of 83.78% for Q1 2019, up 6299.0% year-over-year from 1.31% in Q1 2018, and down 13.35% quarter-over-quarter from 96.69% in Q4 2018.
Plus Therapeutics (PSTV) Gross Margin (2011 - 2019) Analysis & Trends
Plus Therapeutics (PSTV) has 9 years of Gross Margin data on file, last reported at 83.78% in Q1 2019.
- Gross Margin for Q1 2019 came in at 83.78%, up 6299.0% year-over-year; the trailing twelve-month figure through Mar 2019 was 61.05% (up 4610.0% YoY), and the FY2018 annual result was 82.48%, up 7705.0% from the prior year.
- Gross Margin eased to 83.78% in Q1 2019 per PSTV's latest filing, from 96.69% in the prior quarter.
- Over five years, Gross Margin peaked at 96.69% in Q4 2018 and troughed at 21.15% in Q1 2017.
- A 5-year average of 31.31% and a median of 27.04% in 2017 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2017 and 2018: Gross Margin slumped 7861 bps in 2017, then surged 9231 bps in 2018.
- A 5-year view of Gross Margin shows it stood at 49.16% in 2015, then decreased by 28 bps to 35.54% in 2016, then tumbled by 88 bps to 4.38% in 2017, then jumped by 2107 bps to 96.69% in 2018, then declined by 13 bps to 83.78% in 2019.
- Business Quant data shows PSTV's Gross Margin at 83.78% in Q1 2019, 96.69% in Q4 2018, and 26.81% in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 79.04% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 83.78% |
| Dec 31, 2018 | 96.69% |
| Sep 30, 2018 | 26.81% |
| Jun 30, 2018 | 4.55% |
| Mar 31, 2018 | 20.79% |
| Dec 31, 2017 | 4.38% |
| Sep 30, 2017 | -4.28% |
| Jun 30, 2017 | 27.04% |
| Mar 31, 2017 | -21.15% |
| Dec 31, 2016 | 35.54% |
| Sep 30, 2016 | 15.46% |
| Jun 30, 2016 | 48.05% |
| Mar 31, 2016 | 57.46% |
| Dec 31, 2015 | 49.16% |
| Sep 30, 2015 | 34.46% |
| Jun 30, 2015 | 19.70% |
| Mar 31, 2015 | 33.81% |
| Dec 31, 2014 | 42.65% |
| Sep 30, 2014 | 34.94% |
| Jun 30, 2014 | 18.07% |